AI System Generates Novel Virus Variants to Combat Bacterial Infections

Researchers have developed a large language model capable of designing genetically distinct versions of bacteriophages—viruses that target and kill bacteria. The AI system creates variants that maintain effectiveness while diverging significantly from known sequences, potentially enabling the development of new therapeutic agents against antibiotic-resistant pathogens.

Why it matters: This breakthrough demonstrates how generative AI can accelerate drug discovery in virology and synthetic biology, offering a scalable approach to designing targeted therapeutics in an era of rising antimicrobial resistance.